chr15-33670530-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_001036.6(RYR3):​c.5834C>T​(p.Pro1945Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000282 in 1,594,622 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

2
7
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 4.20

Publications

1 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.5834C>T p.Pro1945Leu missense_variant Exon 38 of 104 ENST00000634891.2 NP_001027.3 Q15413-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.5834C>T p.Pro1945Leu missense_variant Exon 38 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152004
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000217
AC:
5
AN:
230266
AF XY:
0.0000240
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000468
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000243
AC:
35
AN:
1442500
Hom.:
0
Cov.:
31
AF XY:
0.0000307
AC XY:
22
AN XY:
716942
show subpopulations
African (AFR)
AF:
0.0000621
AC:
2
AN:
32230
American (AMR)
AF:
0.00
AC:
0
AN:
39732
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24754
East Asian (EAS)
AF:
0.0000506
AC:
2
AN:
39560
South Asian (SAS)
AF:
0.0000242
AC:
2
AN:
82694
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52940
Middle Eastern (MID)
AF:
0.00124
AC:
7
AN:
5636
European-Non Finnish (NFE)
AF:
0.0000190
AC:
21
AN:
1105466
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000941
AC XY:
7
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41502
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10580
Middle Eastern (MID)
AF:
0.00342
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000658
Hom.:
0
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.000255
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jun 21, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.5834C>T (p.P1945L) alteration is located in exon 38 (coding exon 38) of the RYR3 gene. This alteration results from a C to T substitution at nucleotide position 5834, causing the proline (P) at amino acid position 1945 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Epileptic encephalopathy Uncertain:1
Aug 31, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline with leucine at codon 1945 of the RYR3 protein (p.Pro1945Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs375210672, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with RYR3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Uncertain
0.038
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
18
DANN
Benign
0.85
DEOGEN2
Uncertain
0.69
D;.;.;.;.
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.25
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D;D;D;D;D
M_CAP
Benign
0.067
D
MetaRNN
Uncertain
0.54
D;D;D;D;D
MetaSVM
Uncertain
0.20
D
MutationAssessor
Benign
1.8
L;L;.;.;.
PhyloP100
4.2
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-4.7
.;D;D;.;.
REVEL
Uncertain
0.34
Sift
Benign
0.18
.;T;T;.;.
Polyphen
0.051
B;B;.;.;.
Vest4
0.67
MVP
0.41
MPC
0.20
ClinPred
0.56
D
GERP RS
4.5
Varity_R
0.22
gMVP
0.38
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375210672; hg19: chr15-33962731; API